Vice President, ERP (Business Partner + Bluestream Lead) at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceuticals, Life SciencesIndustries

Requirements

Deep expertise in SAP program leadership
Strong understanding of life sciences business processes and regulatory requirements
Proven track record of successfully delivering and sustaining complex ERP transformations
Experience leading geographically dispersed teams of dedicated and matrixed internal business, IT, and PMO resources
Ability to provide strategic direction and make trade-offs between ease of implementation and long-term sustainment
Willingness to travel up to 30% globally
Location in Foster City, California (reporting to the Chief Information Officer)

Responsibilities

Define and execute the SAP program vision and roadmap aligned with corporate strategy and regulatory requirements
Serve as the single leader for the SAP transformation, ensuring alignment with cross-functional business and IT senior executives
Champion business process and master data strategies that enhance operational efficiency, data integrity, and accelerate patient-centric outcomes
Shape and lead program governance structures, including steering committees and executive reporting cadences
Manage program scope, budget, timelines, and vendor relationships including SAP, system integrators, and offshore partners
Set release strategy and timelines based on business constraints and program priorities
Establish, monitor, and communicate KPIs and value realization metrics for program delivery and sustainment
Ensure adherence to GxP, SOX, and other regulatory frameworks relevant to the life sciences industry
Manage the post-implementation SAP IT COE and establish ongoing, cross-functional governance, practices, and resourcing to drive continuous improvement and automation
Partner with leaders across R&D, Manufacturing, Quality, Supply Chain, Commercial, Kite, and Finance to ensure SAP solutions meet business needs
Drive alignment between global and regional teams to support harmonized processes and data standards
Facilitate collaboration between IT, business stakeholders, and external partners to ensure seamless execution
Lead business engagement and organizational change management planning and execution to ensure successful adoption across all levels of the enterprise
Manage risks (inferred from incomplete "Risk & Co" section)

Skills

SAP

ERP

Program Leadership

Digital Transformation

Regulatory Compliance

Business Processes

SAP Implementation

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free